Enter your search term below:
ISCT Asia Pacific (APAC) Industry Committee Furthering ISCT’s role in facilitating global and regional strategic partnerships, in March 2022, ISCT Industry Leadership launched the Asia Pacific (APAC) Industry Committee, expanding the ISCT Industry portfolio. The APAC Industry...
From the Editor Gene Therapy: In Search of Silver Linings Dr Rounak Dubey, MD Junior Associate Editor, ISCT Telegraft Assistant Professor Transfusion Medicine NRI Academy of Medical Sciences, India “You can’t connect the dots looking forward; you can only connect them...
Members in the News: Ori Biotech and CTMC partner to accelerate novel cell therapy delivery London, UK, and Houston, TX, US, September 13, 2022 – Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing technologies, and the Cell Therapy Manufacturing Center (CTMC),...
Past Awardee of the inaugural ISCT Europe Master Program 2020/2021 Alejandro Barquero, MPharm, MSc CMC Manager, Corrgene In 2020, I joined the ISCT community in line with my increasing commitment to the cell & gene therapies field. I felt it was the right time to...
by Miguel Forte, M.D., Ph.D. and Bruce Levine, Ph.D. The field of C> is experiencing great growth, and we are witnessing a growing number of products being approved. The hope would be that these products following regulatory approvals and marketing efforts will be reaching patients...
Scholarship recipient of the 2021/2022 ISCT Europe Scholarship and the Master in Manufacturing of ATMPs Katja Sirviö, M.Sc. (Pharm.) Cell Therapy Process Development Manager Kuopio Center for Gene and Cell Therapy (KCT), Kuopio, Finlandanager The Master degree in...